Antidepressant use and colorectal cancer risk: A systematic review and meta-analysis of epidemiological studies.

Eur NeuropsychopharmacolMay 17, 2026 (epub)

Cuiling Wei, Oscar Mahasriariyawong, Peng Wu et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis examined the relationship between antidepressant use and colorectal cancer (CRC) risk across 15 observational studies. The analysis revealed a significantly lower CRC risk associated with antidepressant use, with a pooled odds ratio of 0.88 (95% CI: 0.87, 0.95) and a pooled hazard ratio of 0.85 (95% CI: 0.74, 0.97), particularly for selective serotonin reuptake inhibitors and tricyclic antidepressants.

Key findings

  • Pooled odds ratio for CRC risk associated with antidepressant use was 0.88 (95% CI: 0.87, 0.95).
  • Pooled hazard ratio for CRC risk was 0.85 (95% CI: 0.74, 0.97).
  • SSRIs and TCAs both had a pooled odds ratio of 0.90 (95% CI: 0.84, 0.96) for CRC risk.
  • No significant relationship was found between antidepressant exposure patterns and CRC risk.

Why it matters

Understanding the potential protective effects of antidepressants against colorectal cancer can inform clinical decision-making, particularly in patients with comorbid mental health conditions. This dual benefit may influence treatment strategies and patient counseling.

Source

Published in Eur Neuropsychopharmacol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Gastroenterology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.